Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: Outcomes from a controlled nonrandomized long-term study

Journal of the American College of Cardiology

Volumn 42, Issue 2, 2003, Pages 185-197

  Pappone, Carlo ^a   Rosanio, Salvatore ^a   Augello, Giuseppe ^a   Gallus, Giuseppe ^b   Vicedomini, Gabriele ^a   Mazzone, Patrizio ^a   Gulletta, Simone ^a   Gugliotta, Filippo ^a   Pappone, Alessia ^a   Santinelli, Vincenzo ^a   Tortoriello, Valter ^a   Sala, Simone ^a   Zangrillo, Alberto ^a   Crescenzi, Giuseppe ^a   Benussi, Stefano ^a   Alfieri, Ottavio ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; DISOPYRAMIDE; FLECAINIDE; HEPARIN; QUINIDINE; SOTALOL; WARFARIN;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CATHETER ABLATION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEALTH STATUS; HEART ATRIUM FIBRILLATION; HEART ATRIUM FUNCTION; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PULMONARY VEIN; QUALITY OF LIFE; RECURRENT DISEASE; SINUS RHYTHM; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0038300657     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(03)00577-1     Document Type: Article

References (21)

1. Fuster V, Ryden LE, Asinger RW, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. Circulation 2001;104:2118-50.
2. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults. JAMA 2001;285:2370-5.
3. Wolf PA, Mitchell JB, Baker CS, et al. Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch Intern Med 1998;158:229-34.
4. Luderitz B, Jung W. Quality-of-life in patients with atrial fibrillation. Arch Intern Med 2000;160:1749-57.
5. Sopher SM, Camm AJ, Atrial fibrillation. Maintenance of sinus rhythm versus rate control. Am J Cardiol 1996;77:24A-37A.
6. Falk RH. Atrial fibrillation. N Engl J Med 2001;344:1067-78.
7. Roy D, Talajic M, Dorian P, et al. Amiodarone to prevent recurrence of atrial fibrillation. N Engl J Med 2000;342:913-20.
8. Flaker GC, Blackshear JL, McBride R, et al. Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. J Am Coll Cardiol 1992;20:527-32.
9. Scheinman MM, Morady F. Non-pharmacologic approaches to atrial fibrillation. Circulation 2001;103:2120-5.
10. Pappone C, Oreto G, Lamberti F, et al. Catheter ablation of paroxysmal atrial fibrillation using a 3D mapping system. Circulation 1999;100:1203-8.
11. Haissaguerre M, Jais P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998;339:659-66.
12. Pappone C, Rosanio S, Oreto G, et al. Circumferential radiofrequency ablation of pulmonary vein ostia. Circulation 2000;102:2619-28.
13. Pappone C, Oreto G, Rosanio S, et al. Atrial electroanatomical remodeling after circumferential radiofrequency pulmonary vein ablation. Circulation 2001;104:2539-44.
14. Oral H, Knight BP, Tada H, et al. Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation. Circulation 2002;105:1077-81.
15. Ware JE Jr., Kosinski M. SF-36 Physical and Mental Health Summary Scales: A Manual for Users of Version 1. 2nd edition. Lincoln, RI: QualityMetric Inc., 2001:5-90.
16. Apolone G, Mosconi P. The Italian SF-36 health survey: translation, validation and norming. J Clin Epidemiol 1998;51:1025-36.
17. Italian Annual Statistical Report 2001. Italy's National Statistical Institute (ISTAT) 2001:58-9.
18. Albert PS. Longitudinal data analysis in clinical trials. Stat Med 1999;18:1707-32.
19. Hohnloser SH, Kuck KH, Lilienthal J, et al. Rhythm or rate control in atrial fibrillation: Pharmacological Intervention in Atrial Fibrillation (PIAF) a randomized trial. Lancet 2000;356:1789-94.
20. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347:1825-33.
21. Van Gelder I, Hagens VE, Bosker HA, et al., for the Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation (RACE) study group. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002;347:1834-40.